Inactive Instrument

Company BG Medicine Nasdaq

Equities

Pharmaceuticals

End-of-day quote Nasdaq
- USD 0.00% Intraday chart for BG Medicine

Business Summary

BG Medicine, Inc. (BG Medicine) is a commercial-stage diagnostics company. The Company is engaged in commercializing diagnostic products that may be used to help guide the care and management of patients suffering from heart failure and related disorders. The Company's BGM Galectin-3 Test is an in vitro diagnostic device that employs a manual micro-titer platform to measure galectin-3 levels in blood plasma or serum for use as an aid in assessing the prognosis of chronic heart failure in conjunction with clinical evaluation. The automated galectin-3 tests are being developed and commercialized by its diagnostic instrument manufacturing partners and will be performed on its partners' automated platforms. The Company's CardioSCORE test is a multi-analyte biomarker-based blood test that was designed as an aid in the assessment of near-term risk for atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.

Sales per Business

USD in Million2014Weight2015Weight Delta
Diagnostic Solutions
89.7 %
3 100.0 % 1 89.7 % -49.59%
Product Fee
8.9 %
- - 0 8.9 % -
Partnership Revenue
1.3 %
- - 0 1.3 % -

Sales per region

USD in Million2014Weight2015Weight Delta
United States
100.0 %
3 100.0 % 2 100.0 % -43.81%

Managers

Managers TitleAgeSince
Director of Finance/CFO 73 13-12-02

Members of the board

Members of the board TitleAgeSince
Chairman 69 15-05-11
Director/Board Member 57 16-02-03
Director/Board Member 67 15-11-16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 1,474,443 0 0 100.00 %
Stock B 1 11,374,360 11,374,360 ( 100.00 %) 0

Company contact information

BG Medicine, Inc.

124 Washington Street Suite 101

02035, Foxboro

+781 890 1199

http://www.bg-medicine.com
address BG Medicine